JPM26: GE HealthCare’s CEO maintains disciplined M&A strategy

GE HealthCare CEO Peter Arduini has highlighted the company’s disciplined attack to M&A successful bid to “fill gaps and adhd tuck-ins” to its portfolio, portion besides operating arsenic a institution that is well-positioned to beforehand its portfolio done integrated concern and merchandise development.

Arduini reflected connected the approach, utilizing the company’s caller acquisition of aesculapian imaging bundle supplier Intelerad to contextualise his views, astatine this year’s J.P. Morgan Healthcare Conference successful San Francisco, held from 12 to 15 January.

GE HealthCare moved to get Intelerad successful a $2.3bn statement successful November 2025, with the transaction expected to adjacent successful H1 2026.

For GE HealthCare, Arduini said the Canadian institution volition present a cloud-first, artificial quality (AI) enablement for imaging successful an ecosystem.

AI is having a profound power connected the healthcare space, with the technology’s exertion particularly pronounced successful the aesculapian imaging abstraction arsenic a means to streamline efficiencies and glean deeper insights into the likes of CT scans and sonograms. According to GlobalData analysis, AI successful healthcare is forecast to scope a $19bn valuation by 2027.

Looking astatine the imaging marketplace today, portion determination are in- and out-patient solutions, regarding an integrated endeavor attack for imaging, Arduini stated that determination is not truly a afloat level solution that tin orchestrate and execute AI applications that is not made by GE HealthCare.

“They could beryllium made by us. They could beryllium developed in-house. They could beryllium third-party applications; immoderate the case, they heighten workflows,” Arduini continued.

“We deliberation Intelerad is going to beryllium a large tuck-in acceptable for GE HealthCare successful this regard, and an important portion of our precision attraction journey,” Arduini concluded.

The woody for Intelerad came successful the aforesaid period GE HealthCare revealed full Q3 revenues of $5.1bn, up 4% successful integrated maturation compared to the aforesaid play successful 2024. This led the institution to rise its 2025 guidance.

Another talking constituent successful Arduini’s J.P. Morgan presumption surrounded the steps GE HealthCare has taken to simplify its CT portfolio. Arduini highlighted that successful caller years, the company’s CT portfolio has been slimmed down from ‘roughly’ 15-16 configurations and 10 tables down to 3 successful caller years, with the purpose to trim complexity for customers and little interior costs.

Summing up GE Healthcare’s guardant outlook, Arduini shared that implicit time, the institution wants to beryllium measured little arsenic an imaging hardware vendor, and arsenic much of a healthcare solutions provider.

Sign up present to person regular updates connected the latest healthcare manufacture trends emerging from the JP Morgan Healthcare Conference 2026.